Prolactin secretion in patients treated with various drugs: phenothiazines, tricyclic antidepressants, reserpine, and methyldopa.
D000639:Amitriptyline / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use*; D002746:Chlorpromazine / Q000008:administration & dosage; D002986:Clinical Trials as Topic; D005476:Fluphenazine / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007099:Imipramine / Q000627:therapeutic use; D007273:Injections, Intramuscular; D008750:Methyldopa / Q000627:therapeutic use*; D010640:Phenothiazines / Q000627:therapeutic use*; D011388:Prolactin / Q000097:blood / Q000378:metabolism*; D011395:Promazine / Q000627:therapeutic use; D012110:Reserpine / Q000627:therapeutic use*; D013268:Stimulation, Chemical; D013997:Time Factors; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D000928:Antidepressive Agents; D010640:Phenothiazines; D014149:Tranquilizing Agents; D000639:Amitriptyline; D008750:Methyldopa; D012110:Reserpine; D011388:Prolactin; D011395:Promazine; D007099:Imipramine; D005476:Fluphenazine; D002746:Chlorpromazine